Ignite Creation Date:
2025-12-24 @ 8:03 PM
Ignite Modification Date:
2025-12-29 @ 11:37 PM
Study NCT ID:
NCT00366704
Status:
TERMINATED
Last Update Posted:
2013-02-11
First Post:
2006-08-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study Comparing Bifeprunox to Risperidone in Treatment of Outpatients With Schizophrenia With Weight as Primary Endpoint
Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-11
Start Date Type:
None
Primary Completion Date:
2008-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-03
Completion Date Type:
ACTUAL
First Submit Date:
2006-08-17
First Submit QC Date:
None
Study First Post Date:
2006-08-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2013-02-11
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2013-02-07
Last Update Post Date:
2013-02-11
Last Update Post Date Type:
ESTIMATED